Maria Debiec-Rychter
Katholieke Universiteit Leuven
H-index: 77
Europe-Belgium
Top articles of Maria Debiec-Rychter
Optical Genome Mapping for comprehensive cytogenetic analysis of soft tissue and bone tumours for diagnostic purposes.
The Journal of Molecular Diagnostics
2024/2/22
Ripretinib inhibits polyclonal drug-resistant KIT oncoproteins: the next step forward in gastrointestinal stromal tumor therapy
Gastrointestinal Stromal Tumor
2023/5/15
Maria Debiec-Rychter
H-Index: 41
Piotr Rutkowski
H-Index: 2
Case report: Cardiac intimal sarcoma in a young child
Frontiers in Pediatrics
2023
Maria Debiec-Rychter
H-Index: 41
Plocabulin, a Novel Tubulin Inhibitor, Has Potent Antitumour Activity in Patient-Derived Xenograft Models of Soft Tissue Sarcoma
International Journal of Molecular Sciences
2022/7/5
Maria Debiec-Rychter
H-Index: 41
XenoSarc: patient-derived xenograft (PDX) models of soft tissue sarcoma (STS) and their histopathological and molecular characterization
Cancer Research
2022/6/15
Advances in therapy of succinate dehydrogenase (SDH)-deficient gastrointestinal stromal tumor
Gastrointestinal Stromal Tumor
2022/6/5
Piotr Rutkowski
H-Index: 2
Maria Debiec-Rychter
H-Index: 41
Correlation of immunological and molecular profiles with response to crizotinib in alveolar soft part sarcoma: an exploratory study related to the EORTC 90101 “CREATE” trial
International Journal of Molecular Sciences
2022/5/19
Detection of MDM2 amplification by shallow whole genome sequencing of cell-free DNA of patients with dedifferentiated liposarcoma
Plos one
2022/1/5
Joanna Przybyl
H-Index: 10
Nam Bui
H-Index: 11
Maria Debiec-Rychter
H-Index: 41
Matt Van De Rijn
H-Index: 55
SDH-deficient gastrointestinal stromal tumours
Nowotwory. Journal of Oncology
2022
Comprehensive molecular analysis of inflammatory myofibroblastic tumors reveals diverse genomic landscape and potential predictive markers for response to crizotinib
Clinical Cancer Research
2021/12/15
Histopathological and molecular profiling of clear cell sarcoma and correlation with response to crizotinib: an exploratory study related to EORTC 90101 “CREATE” trial
Cancers
2021/12/1
Piotr Rutkowski
H-Index: 2
Maria Debiec-Rychter
H-Index: 41
Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE
European Journal of Cancer
2021/10/1
Maria Debiec-Rychter
H-Index: 41
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13
Molecular Cancer Research
2021/6/1
Maria Debiec-Rychter
H-Index: 41
Management of synovial sarcoma in a tertiary referral center: A retrospective analysis of 134 patients
Oncology Research and Treatment
2021/5/5
Comprehensive targeted next‐generation sequencing approach in the molecular diagnosis of gastrointestinal stromal tumor
Genes, Chromosomes and Cancer
2021/4
Main Repositories and Databases Used in Ewing Sarcoma Research
Ewing Sarcoma: Methods and Protocols
2021
Maria Debiec-Rychter
H-Index: 41
Anti-tumor activity of the MDM2-TP53 inhibitor BI-907828 in dedifferentiated liposarcoma patient-derived xenograft models harboring MDM2 amplification
Clinical and Translational Oncology
2020/4
Differential antitumor activity of compounds targeting the ubiquitin-proteasome machinery in gastrointestinal stromal tumor (GIST) cells
Scientific Reports
2020/3/20
Maria Debiec-Rychter
H-Index: 41
Skeletal muscle tumors
Adipocytic, Vascular and Skeletal Muscle Tumors: A Practical Diagnostic Approach
2020
Maria Debiec-Rychter
H-Index: 41
Adipocytic tumors
Adipocytic, Vascular and Skeletal Muscle Tumors: A Practical Diagnostic Approach
2020
Maria Debiec-Rychter
H-Index: 41
Co-Authors
